With the help of policies, the standardization development of Chinese herbal medicines is on the fast track

Due to the particularity, complexity and historical reasons of Chinese herbal medicines, the quality of Chinese herbal medicines has always been uneven and mixed
.
Based on the 2013-2021 "National Drug Sampling Annual Report", the industry found that in the special sampling inspection of Chinese herbal medicines carried out by the State Food and Drug Administration, the main problems that have been found for many years are: first, the problem of substituting and doping of counterfeit products, and the second is The problem of excessive residues of exogenous harmful substances, and the third is the problem of irregular harvesting and processing
.
In this regard, the industry believes that with the continuous support and promotion of the traditional Chinese medicine industry from the state to the locality, and the continuous improvement of the acceptance of traditional Chinese medicine in overseas markets, China's traditional Chinese medicine industry is ushering in the "golden period" of development.
The supervision on the quality of Chinese herbal medicines will also become more and more strict, and the above manifestations will become the key issues of national rectification
.
It is understood that the four departments of the State Food and Drug Administration, the Ministry of Agriculture and Rural Affairs, the State Forestry and Grass Administration, and the State Administration of Traditional Chinese Medicine have jointly issued a new version of the "Quality Management Practice for Chinese Medicinal Materials" (GAP).
Equipment and tools, base site selection, seeds and seedlings or other propagating materials, planting and breeding, harvesting and processing at the place of origin, release and storage and transportation, documents, quality inspection, internal audit and other aspects have been described in detail
.
It is worth mentioning that, for the first time, requirements such as "tracing the production of traditional Chinese medicinal materials" and "the person in charge of the enterprise shall be responsible for the quality of traditional Chinese medicinal materials" are also proposed for the first time
.
In addition, there are stricter and more detailed requirements for the quality standards of medicinal materials.
At the operational level, while giving base enterprises more flexibility, they also endow enterprises with more responsibilities and obligations
.
It is generally believed in the industry that the standard will accelerate the development of China's traditional Chinese medicine industry in the direction of standardization and standardization
.
According to the author's understanding, in fact, traditional Chinese medicinal materials have always been prone to errors in the production process and quality control due to problems such as difficulty in preservation
.
Therefore, in response to the problems of processing, counterfeiting, selling and non-standard processing of traditional Chinese medicinal materials, the country and even all parts of the country have been issuing a series of corresponding policy controls
.
Recently, in addition to the new version of the "Quality Management Standards for the Production of Chinese Medicinal Materials" jointly issued by the four departments, many regions have also made it clear that they will promote the standardization and modernization of Chinese medicinal materials industry.

.
For example, with the policy opportunities brought by the Guofa [2022] No.
2 document and the "Guizhou Province's Overall Health Improvement Action Plan (2021-2030)" (Qian Dangfa [2021] No.
36 Document), in 2022 , Guizhou said that it will improve the modernization level of the traditional Chinese medicine industry, grasp the quality control, and promote the high-quality development of the traditional Chinese medicine industry
.
Among them, it is worth mentioning that Guizhou has also made it clear that it will implement the "Hundreds and Tens of Thousands" plan for the Chinese herbal medicine industry
.
Focus on the industrialization development of large varieties and authentic medicinal materials, continue to promote the construction of "customized medicinal gardens", strive to reach about 100 "customized medicinal gardens", accelerate the establishment of 1,000 enterprises on the e-commerce trading platform of traditional Chinese medicinal materials, and standardize the varieties of authentic medicinal materials produced in Guizhou The construction area will be expanded to more than 400,000 mu (including under-forest planting)
.
In general, with the help of the country and localities, the processing and production of Chinese herbal medicines in China will become more and more standardized
.
At the same time, the quality of Chinese herbal medicine products will also continue to improve, which will play an important role in boosting the development of Chinese herbal medicine product brands in China and further enhance industrial benefits
.
In this context, it should be noted that traditional Chinese medicine companies also need to strictly control all aspects, adjust production and operation strategies in a timely manner, and improve product quality, otherwise they will face high illegal costs and even be eliminated
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.